Gene polymorphisms and their role in epilepsy treatment and prognosis

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 382, Issue 2, 2010, Pages 109-118

  Steinlein, Ortrud K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Epilepsy; Polymorphisms; SNP

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PRIMIDONE; SULTIAME; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ABSENCE; BENIGN CHILDHOOD EPILEPSY; BRAIN DAMAGE; DRUG EFFICACY; EPILEPSY; ERYTHEMA; FOCAL EPILEPSY; GENE ACTIVATION; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GRAND MAL EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; MACULOPAPULAR RASH; PATHOGENESIS; PETIT MAL; PROGNOSIS; PROMOTER REGION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; WEST SYNDROME;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; EPILEPSY; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TRANSCRIPTIONAL ACTIVATION;

EID: 77955559820     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-010-0531-8     Document Type: Review

References (84)

1. N Adab U Kini J Vinten J Ayres G Baker J Clayton-Smith H Coyle A Fryer J Gorry J Gregg G Mawer P Nicolaides L Pickering L Tunnicliffe DW Chadwick 2004 The longer term outcome of children born to mothers with epilepsy J Neurol Neurosurg Psychiatry 11 1575 1583 10.1136/jnnp.2003.029132
2. A Alfirevic T Mills P Harrington T Pinel J Sherwood A Jawaid JC Smith RE March BJ Barratt DW Chadwick B Kevin Park M Pirmohamed 2006 Serious carbamazepine-induced hypersensitivity reactions associated with the HSP70 gene cluster Pharmacogenet Genomics 16 287 296 10.1097/01.fpc.0000189800.88596.7a 1:CAS:528:DC%2BD28Xit12ht7s%3D 16538175
3. M Artama A Auvinen T Raudaskoski I Isojärvi J Isojärvi 2005 Antiepileptic drug use of women with epilepsy and congenital malformations in offspring Neurology 64 1874 1878 10.1212/01.WNL.0000163771.96962.1F 1:STN:280:DC%2BD2MzgvFWmug%3D%3D 15955936
4. S Bertrand S Weiland SF Berkovic OK Steinlein D Bertrand 1998 Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy Br J Pharmacol 125 751 760 10.1038/sj.bjp.0702154 1:CAS:528:DyaK1cXnsVaqt7g%3D 9831911
5. FG Bournissen ME Moretti DN Juurlink G Koren M Walker Y Finkelstein 2009 Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: a meta-analysis Epilepsia 50 898 903 10.1111/j.1528-1167. 2008.01858.x 1:CAS:528:DC%2BD1MXksFOqtbw%3D 19178561
6. PA Boxer JJ Cordon ME Mann LC Rodolosi MG Vartanian DM Rock CP Taylor FW Marcoux 1990 Comparison of phenytoin with noncompetitive N-methyl-D-aspartate antagonists in a model of focal brain ischemia in rat Stroke 21 Suppl 11 lll47 lll51
7. E Brodtkorb F Picard 2006 Tobacco habits modulate autosomal dominant nocturnal frontal lobe epilepsy Epilepsy Behav 9 515 520 10.1016/j.yebeh.2006. 07.008 16931165
8. R Brouns N Ursem J Lindemans W Hop S Pluijm E Steegers R Steegers-Theunissen 2008 Polymorphisms in genes related to folate and cobalamin metabolism and the associations with complex birth defects Prenat Diagn 28 485 493 10.1002/pd.2006 1:CAS:528:DC%2BD1cXptVWhsbw%3D 18435414
9. JF Cardenas JM Rho YT Ng 2010 Reversible lamotrigine-induced neurobehavioral disturbances in children with epilepsy J Child Neurol 25 182 187 10.1177/0883073809336874 19494356
10. P Carninci 2010 RNA dust: where are the genes? DNA Res 17 51 59 10.1093/dnares/dsq006 1:CAS:528:DC%2BC3cXkvVymtb0%3D 20211845
11. AS Chaudhry TJ Urban JK Lamba AK Birnbaum RP Remmel M Subramanian S Strom JH You D Kasperaviciute CB Catarino RA Radtke SM Sisodiya DB Goldstein EG Schuetz 2010 CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose J Pharmacol Exp Ther 332 599 611 10.1124/jpet.109.161026 1:CAS:528:DC%2BC3cXltVCkt7Y%3D 19855097
12. WH Chung SI Hung HS Hong MS Hsih LC Yang HC Ho JY Wu YT Chen 2004 Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 486 10.1038/428486a 1:CAS:528:DC%2BD2cXis1Gksro%3D 15057820
13. JA Davies 1995 Mechanisms of action of antiepileptic drugs Seizure 1995 4 267 271 10.1016/S1059-1311(95)80003-4
14. JCS Dean SJ Moore A Osborne J Howe PD Turnpenny 1999 Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene Clin Genet 36 216 220 10.1034/j.1399-0004.1999.560306.x
15. J Dean Z Robertson V Reid QD Wang H Hailey S Moore AD Rasalam P Turnpenny D Lloyd A Cardy D Shaw J Little 2007 Fetal anticonvulsant syndromes and polymorphisms in MTHFR, MTR, and MTRR Am J Med Genet A 143A 2303 2311 10.1002/ajmg.a.31914 1:CAS:528:DC%2BD2sXht1ahs7vI 17853476
16. JC Dean Z Robertson V Reid Q Wang H Hailey S Moore AD Rasalam P Turnpenny D Lloyd D Shaw J Little 2008 A high frequency of the MTHFR 677C > T polymorphism in Scottish women with epilepsy: possible role in pathogenesis Seizure 17 269 275 10.1016/j.seizure.2007.08.003 1:STN:280: DC%2BD1c7mslehtg%3D%3D 17904392
17. YX Ding LP Zou B He WH Yue ZL Liu D Zhang 2010 ACTH receptor (MC2R) promoter variants associated with infantile spasms modulate MC2R expression and responsiveness to ACTH Pharmacogenet Genomics 20 71 76 10.1097/FPC. 0b013e328333a172 1:CAS:528:DC%2BC3cXnvFyksg%3D%3D 20042918
18. SR Eddy 2001 Non-coding RNA genes and the modern RNA world Nat Rev Genet 2 919 929 10.1038/35103511 1:CAS:528:DC%2BD38Xmt1Whu7g%3D 11733745
19. SG Edwards V Hubbard S Aylett D Wren 1999 Concordance of primary generalised epilepsy and carbamazepine hypersensitivity in monozygotic twins Postgrad Med 75 680 681 10.1136/pgmj.75.889.680 1:STN:280: DC%2BD3c%2FoslOlsQ%3D%3D
20. M El Yacoubi C Ledent M Parmentier J Costentin J-M Vaugeois 2009 Adenosine A2A receptor deficient mice are partially resistant to limbic seizures Naunyn-Schmiedeberg's Arch Pharmacol 380 223 232 10.1007/s00210-009-0426-8
21. RH Finnell A Gould O Spiegelstein 2003 Pathobiology and genetics of neural tube defects Epilepsia 44 Suppl 3 14 23 10.1046/j.1528-1157.44.s3.5.x 1:CAS:528:DC%2BD3sXlvFelt7Y%3D 12790882
22. D Franciotta P Kwan E Perucca 2009 Genetic basis for idiosyncratic reactions to antiepileptic drugs Curr Opin Neurol 22 144 149 10.1097/WCO.0b013e328328f276 19262378
23. CA Galimberti M Diegoli I Sartori C Uggetti A Brega A Tartara E Arbustini 2006 Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutation Neurology 67 1715 1717 10.1212/01.wnl.0000242882.58086.9a 1:STN:280:DC%2BD28nmslaktA%3D%3D 17101920
24. DA Greenberg DK Pal 2007 The state of the art in the genetic analysis of the epilepsies Curr Neurol Neurosci Rep 7 320 328 10.1007/s11910-007-0049-8 1:CAS:528:DC%2BD2sXptFGqtLk%3D 17618539
25. ND Greene P Stanier AJ Copp 2009 Genetics of human neural tube defects Hum Mol Genet 18 R113 R129 10.1093/hmg/ddp347 1:CAS:528:DC%2BD1MXhtlCqu7jJ 19808787
26. E Haberlandt C Weger SB Sigl M Rauchenzauner S Scholl-Bürgi K Rostásy D Karall 2010 Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes Pediatr Neurol 42 21 27 10.1016/j.pediatrneurol.2009.07.011 20004858
27. SA Hamed 2010 The multimodal prospects for neuroprotection and disease modification in epilepsy: relationship to its challenging neurobiology Restor Neurol Neurosci 28 323 348 1:CAS:528:DC%2BC3cXmtlSisrw%3D 20479527
28. JC Hoda M Wanischeck D Bertrand OK Steinlein 2009 Pleiotropic functional effects of the first epilepsy-associated mutation in the human CHRNA2 gene FEBS Lett 583 1599 1604 10.1016/j.febslet.2009.04.024 1:CAS:528:DC%2BD1MXmtVelt7s%3D 19383498
29. RC Hogg D Bertrand 2004 Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds Bioorg Med Chem Lett 14 1859 1861 10.1016/j.bmcl.2003.10.075 1:CAS:528:DC%2BD2cXislSqtb0%3D 15050616
30. R Horvath G Hudson G Ferrari N Fütterer S Ahola E Lamantea H Prokisch H Lochmüller R McFarland V Ramesh T Klopstock P Freisinger F Salvi JA Mayr R Santer M Tesarova J Zeman B Udd RW Taylor D Turnbull M Hanna D Fialho A Suomalainen M Zeviani PF Chinnery 2006 Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene Brain 129 1674 1684 10.1093/brain/awl088 16621917
31. International Human Genome Sequencing Consortium 2001 Initial sequencing and analysis of the human genome Nature Nature 409 860 921 10.1038/35057062
32. E Kaaja R Kaaja V Hiilesmaa 2003 Major malformations in offspring of women with epilepsy Neurology 60 575 579 12601095
33. S Kaneko D Battino E Andermann K Wada R Kan A Takeda Y Nakane Y Ogawa G Avanzini C Fumarola T Granata F Molteni G Pardi L Minotti R Canger L Dansky M Oguni I Lopes-Cendas A Sherwin F Andermann MH Seni M Okada T Teranishi 1999 Congenital malformations due to epileptic drugs Epilepsy Res 33 145 158 10.1016/S0920-1211(98)00084-9 1:CAS:528:DyaK1MXhvFGku7s%3D 10094426
34. EK Karlsson K Lindblad-Toh 2008 Leader of the pack: gene mapping in dogs and other model organisms Nat Rev Genet 9 713 725 10.1038/nrg2382 1:CAS:528:DC%2BD1cXhtVSitrnJ 18714291
35. D Kasperaviciūte SM Sisodiya 2009 Epilepsy pharmacogenetics Pharmacogenomics 10 817 836 10.2217/pgs.09.34 19450130
36. CS Ki KA Lee SY Lee HJ Kim SS Cho JH Park S Cho KM Sohn JW Kim 2003 Haplotype structure of the UDP-glucuronosyltransferase 1A1 (UGT1A1) gene and its relationship to serum total bilirubin concentration in a male Korean population Clin Chem 49 2078 2081 10.1373/clinchem.2003.024174 1:CAS:528: DC%2BD3sXpt1ynt7k%3D 14633881
37. DW Kim SK Lee K Chu IJ Jang KS Yu JY Cho SJ Kim 2009 Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy Epilepsy Res 84 86 90 10.1016/j.eplepsyres.2008.12.001 1:CAS:528:DC%2BD1MXivVWju7w%3D 19167193
38. H Kim M Rafiuddin-Shah HC Tu JR Jeffers GP Zambetti JJ Hsieh EH Cheng 2006 Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies Nat Cell Biol 8 1348 1358 10.1038/ncb1499 1:CAS:528: DC%2BD28Xht1Kju73F 17115033
39. U Kini R Lee A Jones S Smith S Ramsden A Fryer J Clayton-Smith 2007 Influence of the MTHFR genotype on the rate of malformations following exposure to antiepileptic drugs in utero Eur J Med Genet 50 411 420 17951123
40. P Kinirons GL Cavalleri R Singh A Shahwan JF Acheson NW Wood DB Goldstein SM Sisodiya CP Doherty N Delanty 2006 A pharmacogenetic exploration of vigabatrin-induced visual field constriction Epilepsy Res 70 144 152 10.1016/j.eplepsyres.2006.03.012 1:CAS:528:DC%2BD28XotVCksb8%3D 16675198
41. MJ Kjeldsen LA Corey MH Solaas ML Friis JR Harris KO Kyvik K Christensen JM Pellock 2005 Genetic factors in seizures: a population-based study of 47, 626 US, Norwegian and Danish twin pairs Twin Res Hum Genet 8 138 147 10.1375/twin.8.2.138 15901477
42. U Klotz 2007 The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications Clin Pharmacokinet 46 271 279 10.2165/00003088-200746040-00001 1:CAS:528: DC%2BD2sXlt1Grsro%3D 17375979
43. AA Komar 2007 Silent SNPs: impact on gene function and phenotype Pharmacogenomics 2007 8 1075 1080 10.2217/14622416.8.8.1075
44. N Krivoy M Taer MG Neuman 2006 Antiepileptic drug-induced hypersensitivity syndrome reactions Curr Drug Saf 1 289 299 10.2174/ 157488606777934459 1:CAS:528:DC%2BD28XnsFWgsrY%3D 18690940
45. H Kutt F McDowell 1968 Management of epilepsy with diphenylhydantoin sodium dosage regulation for problem patients JAMA 203 969 972 10.1001/jama.203.11.969 1:STN:280:DyaF1c7mt1yluw%3D%3D 5694319
46. P Kwan L Baum V Wong PW Ng CH Lui NC Sin AC Hui E Yu LK Wong 2007 Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese Epilepsy Behav 11 112 117 10.1016/j.yebeh.2007.04.013 17521963
47. H Lohi EJ Young SN Fitzmaurice C Rusbridge EM Chan M Vervoort J Turnbull XC Zhao L Ianzano AD Paterson NB Sutter EA Ostrander C André GD Shelton CA Ackerley SW Scherer BA Minassian 2005 Expanded repeat in canine epilepsy Science 307 81 10.1126/science.1102832 1:CAS:528:DC%2BD2MXitlantA%3D%3D 15637270
48. F López-Muñoz R Ucha-Udabe C Alamo 2005 The history of barbiturates a century after their clinical introduction Neuropsychiatr Dis Treat 1 329 343 18568113
49. AE Lehesjoki 2003 Molecular background of progressive myoclonus epilepsy EMBO J 22 3473 3478 10.1093/emboj/cdg338 1:CAS:528:DC%2BD3sXlsl2ltbg%3D 12853462
50. Y Li D Buckley S Wang CD Klaassen XB Zhong 2009 Genetic polymorphisms in the TATA box and upstream phenobarbital-responsive enhancer module of the UGT1A1 promoter have combined effects on UDP-glucuronosyltransferase 1A1 transcription mediated by constitutive androstane receptor, pregnane X receptor, or glucocorticoid receptor in human liver Drug Metab Dispos 37 1978 1986 10.1124/dmd.109.027409 1:CAS:528:DC%2BD1MXhtVOrsrfP 19541828
51. CM Lin P Thajeb 2007 Valproic acid aggravates epilepsy due to MELAS in a patient with an A3243G mutation of mitochondrial DNA Metab Brain Dis 22 105 109 10.1007/s11011-006-9039-9 1:CAS:528:DC%2BD2sXisVejsLY%3D 17226098
52. C Lonjou N Borota P Sekulae N Ledger L Thomas S Halevy L Naldi JN Bouwes-Bavinck A Sidoroff C de Toma M Schumacher JC Roujeau A Hovnanian M Mockenhaupt 2008 A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs Pharmacogenet Genomics 18 99 107 10.1097/FPC.0b013e3282f3ef9c 1:CAS:528:DC%2BD1cXlsVWgtw%3D%3D 18192896
53. JJ Luszeczki JZ Wu G Raszewski SJ Czuczwar 2009 Isobolographic characterization of interactions of retigabine with carbamazepine, lamotrigine, and valproate in the mouse maximal electroshock-induced seizure model Naunyn-Schmiedeberg's Arch Pharmacol 379 163 179 10.1007/s00210-008-0349-9
54. K Mamiya I Ieiri J Shimamoto E Yukawa J Imai H Ninomiya H Yamada K Otsubo S Higuchi N Tashiro 1998 The effects of genetic polymorphisms of CYP2C9 and CYP2C19 on phenytoin metabolism in Japanese adult patients with epilepsy: studies in stereoselective hydroxylation and population pharmacokinetics Epilepsia 39 1317 1323 10.1111/j.1528-1157.1998.tb01330.x 1:CAS:528: DyaK1MXitFCjug%3D%3D 9860067
55. CB Man P Kwan L Baum E Yu KM Lau AS Cheng MH Ng 2007 Association between HLA-B* 1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese Epilepsia 48 1015 1018 10.1111/j.1528-1167.2007.01022.x 1:CAS:528:DC%2BD2sXms1ygsrw%3D 17509004
56. R McFarland G Hudson RW Taylor SH Green S Hodges PJ McKiernan PF Chinnery V Ramesh 2008 Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1) Arch Dis Child 93 151 153 10.1136/adc.2007.122911 1:STN:280:DC%2BD1c%2FlsVGhsg%3D%3D 18208989
57. LK McCluggage SA Voils MR Bullock 2009 Phenytoin toxicity due to genetic polymorphism Neurocrit Care 10 222 224 10.1007/s12028-008-9165-9 19030785
58. B Murphy M Dunleavy S Shinoda C Schindler R Meller C Bellver-Estelles S Hatazaki P Dicker A Yamamoto I Koegel X Chu W Wang Z Xiong J Prehn R Simon D Henshall 2007 Bcl-w protects hippocampus during experimental status epilepticus Am J Pathol 171 1258 1268 10.2353/ajpath.2007.070269 1:CAS:528: DC%2BD2sXht1Smtr%2FL 17702891
59. M Nakajima N Sakata N Ohashi T Kume T Yokoi 2002 Involvement of multiple UDP-glucuronosyltransferase 1A isoforms in glucuronidation of 5-(4′-hydroxyphenyl)-5-phenylhydantoin in human liver microsomes Drug Metab Dispos 30 1250 1256 10.1124/dmd.30.11.1250 1:CAS:528:DC%2BD38XotFyku7o%3D 12386132
60. AM Oberbauer JM Belanger DI Grossman KR Regan TR Famula 2010 Genome-wide linkage scan for loci associated with epilepsy in Belgian shepherd dogs BMC Genet 11 35 10.1186/1471-2156-11-35 20441595
61. IS Owens NK Basu R Banerjee 2002 UDP-glucuronosyltransferases: gene structures of UGT1 and UGT2 families Meth Enzymol 400 1 22 10.1016/S0076- 6879(05)00001-7
62. T Petkov G Pehlivanov I Grozdev S Kavaklieva N Tsankov 2007 Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome Eur J Dermatol 17 422 427 1:CAS:528:DC%2BD2sXht1eiu7nF 17673387
63. F Picard S Bertrand OK Steinlein D Bertrand 1999 Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine Epilepsia 40 1198 1209 10.1111/j.1528-1157. 1999.tb00848.x 1:CAS:528:DyaK1MXmslWgur8%3D 10487182
64. M Pirmohamed K Lin D Chadwick BK Park 2001 TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients Neurology 56 890 896 1:CAS:528:DC%2BD3MXjsFSns7o%3D 11294926
65. N Ramachandran JM Girard J Turnbull BA Minassian 2009 The autosomal recessively inherited progressive myoclonus epilepsies and their genes Epilepsia 50 Suppl 5 29 36 10.1111/j.1528-1167.2009.02117.x 1:CAS:528: DC%2BD1MXms1Sktbc%3D 19469843
66. J Ramírez BJ Komoroski S Mirkov AY Graber DL Fackenthal EG Schuetz S Das MJ Ratain F Innocenti SC Strom 2006 Study of the genetic determinants of UGT1A1 inducibility by phenobarbital in cultured human hepatocytes Pharmacogenet Genomics 16 79 86 10.1097/01.fpc.0000182784.77630.48 16424820
67. AK Rehni TG Singh N Singh S Arora 2010 Tramadol-induced seizurogenic effect: a possible role of opioid-dependent histamine (H1) receptor activation-linked mechanism Naunyn-Schmiedeberg's Arch Pharmacol 381 11 19 10.1007/s00210-009-0476-y 1:CAS:528:DC%2BD1MXhsFGrt7fF
68. MB Sánchez JL Herranz C Leno R Arteaga A Oterino EM Valdizán JM Nicolás J Adín JA Armijo 2010 Genetic factors associated with drug-resistance of epilepsy: relevance of stratification by patient age and aetiology of epilepsy Seizure 19 93 101 10.1016/j.seizure.2009. 12.004 20064729
69. T Seo T Ishitsu N Ueda N Nakada K Yurube K Ueda K Nakagawa 2006 ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients Pharmacogenomics 7 551 561 10.2217/14622416.7.4.551 1:CAS:528:DC%2BD28XmvV2jsbc%3D 16753003
70. T Seo T Ishitsu K Oniki T Abe T Shuto K Nakagawa 2008 ABCC2 haplotype is not associated with drug-resistant epilepsy J Pharm Pharmacol 60 631 635 10.1211/jpp.60.5.0009 1:CAS:528:DC%2BD1cXltlemtrk%3D 18416940
71. A Siddiqui R Kerb ME Weale U Brinkmann A Smith DB Goldstein NW Wood SM Sisodiya 2003 Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1 N Engl J Med 348 1442 1448 10.1056/NEJMoa021986 1:CAS:528:DC%2BD3sXivVCgs7g%3D 12686700
72. CM Smith SR Faucette H Wang EL LeCluyse 2005 Modulation of UDP-glucuronosyltransferase 1A1 in primary human hepatocytes by prototypical inducers J Biochem Mol Toxicol 19 96 108 10.1002/jbt.20058 1:CAS:528: DC%2BD2MXjvFSlurw%3D 15849716
73. OK Steinlein JC Mulley P Propping RH Wallace HA Phillips GR Sutherland IE Scheffer SF Berkovic 1995 A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy Nat Genet 11 201 203 10.1038/ng1095-201 1:CAS:528:DyaK2MXosF2rt74%3D 7550350
74. OK Steinlein A Magnusson J Stoodt S Bertrand S Weiland SF Berkovic KO Nakken P Propping D Bertrand 1997 An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy Hum Mol Genet 6 943 947 10.1093/hmg/6.6.943 1:CAS:528:DyaK2sXjs1Ogs7Y%3D 9175743
75. OK Steinlein 2008 Human disorders caused by the disruption of the regulation of excitatory neurotransmission Results Probl Cell Differ 44 223 242 10.1007/400-2007-034 1:CAS:528:DC%2BD1cXjt1Wh 17589814
76. CE Stafstrom 2010 Mechanisms of action of antiepileptic drugs: the search for synergy Curr Opin Neurol 23 157 163 10.1097/WCO.0b013e32833735b5 1:CAS:528:DC%2BC3cXivV2ku7Y%3D 20125013
77. J Sugatani H Kojima A Ueda S Kakizaki K Yoshinari QH Gong IS Owens M Negishi T Sueyoshi 2001 The phenobarbital response enhancer module in the human bilirubin UDP-glucuronosyltransferase UGT1A1 gene and regulation by the nuclear receptor CAR Hepatology 33 1232 1238 10.1053/jhep.2001.24172 1:CAS:528:DC%2BD3MXjvVahsrc%3D 11343253
78. J Sugatani K Mizushima M Osabe K Yamakawa S Kakizaki H Takagi M Mori A Ikari M Miwa 2008 Transcriptional regulation of human UGT1A1 gene expression through distal and proximal promoter motifs: implication of defects in the UGT1A1 gene promoter Naunyn-Schmiedeberg's arch pharmacol 377 597 605 10.1007/s00210-007-0226-y 1:CAS:528:DC%2BD1cXnsVSqtrs%3D
79. Y Suzuki M Fukuda M Tohyama M Ishikawa M Yasukawa E Ishii 2008 Carbamazepine-induced drug-induced hypersensitivity syndrome in a 14-year-old Japanese boy Epilepsia 49 2118 2121 10.1111/j.1528-1167.2008.01785.x 1:CAS:528:DC%2BD1MXhtVajt7c%3D 18801036
80. V Tamasi P Juvan M Beer D Rozman UA Meyer 2009 Transcriptional activation of PPARalpha by phenobarbital in the absence of CAR and PXR Mol Pharm 6 1573 1581 10.1021/mp9001552 1:CAS:528:DC%2BD1MXhtV2mtb%2FP 19708687
81. M Ufer I Mosyagin H Muhle T Jacobsen S Haenisch R Häsler F Faltraco C Remmler S von Spiczak HK Kroemer U Runge R Boor U Stephani I Cascorbi 2009 Non-response to antiepileptic pharmacotherapy is associated with the ABCC2-24C > T polymorphism in young and adult patients with epilepsy Pharmacogenet Genomics 19 353 362 10.1097/FPC.0b013e328329940b 1:CAS:528:DC%2BD1MXksVCls7s%3D 19415824
82. US Food and Drug Administration (2007). Information for healthcare professionals carbamazepine (marketed as Carbatrol, Equetro, Tegretol, and generics). Available at: http://www.fda.gov/cder/drug/InfoSheets/HCP/ carbamazepineHCP.htm. Accessed 12 Dec 2007
83. HS White 1997 Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs Epilepsia 38 Suppl 1 S9 S17 10.1111/j.1528-1157.1997.tb04523.x 1:CAS:528:DyaK2sXisFyrsr4%3D 9092952
84. A Yamamoto N Murphy CK Schindler NK So S Stohr W Taki JH Prehn DC Henshall 2006 Endoplasmic reticulum stress and apoptosis signaling in human temporal lobe epilepsy J Neuropathol Exp Neurol 65 217 225 1:CAS:528: DC%2BD28Xkslegurw%3D 16651883